NCT02116582 2024-12-06A Study to Evaluate Enzalutamide After Abiraterone in Metastatic Castration-Resistant Prostate CancerAstellas Pharma IncPhase 4 Completed215 enrolled 11 charts
NCT02125357 2020-08-07Sequencing Abiraterone and Enzalutamide in mCRPCBritish Columbia Cancer AgencyPhase 2 Completed202 enrolled